Clinical Trial Update: Anticoagulation Therapy After Splenectomy in Cirrhosis Patient [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating anticoagulation therapy after splenectomy in patients with liver cirrhosis and portal hypertension has completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 1, Phase 2 | Status: COMPLETED